TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 192 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,570,000 | -14.9% | 83,846 | 0.0% | 0.11% | -6.0% |
| Q2 2021 | $6,542,000 | -17.5% | 83,846 | 0.0% | 0.12% | -30.5% |
| Q1 2021 | $7,931,000 | -22.4% | 83,846 | 0.0% | 0.17% | -17.3% |
| Q4 2020 | $10,217,000 | -16.1% | 83,846 | -55.5% | 0.20% | -43.1% |
| Q2 2020 | $12,175,000 | -34.0% | 188,490 | -54.4% | 0.36% | -39.4% |
| Q1 2020 | $18,459,000 | -19.0% | 413,321 | +12.9% | 0.59% | -19.4% |
| Q4 2019 | $22,798,000 | +56.5% | 366,000 | -5.6% | 0.73% | +22.4% |
| Q3 2019 | $14,572,000 | +24.5% | 387,545 | +34.8% | 0.59% | +41.4% |
| Q2 2019 | $11,703,000 | – | 287,545 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |